ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 137 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 8.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $7,000 | -22.2% | 373 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $9,000 | +28.6% | 373 | +71.9% | 0.00% | 0.0% |
Q4 2015 | $7,000 | -65.0% | 217 | -61.6% | 0.00% | -66.7% |
Q3 2015 | $20,000 | -13.0% | 565 | +6.8% | 0.00% | 0.0% |
Q2 2015 | $23,000 | +53.3% | 529 | +4.1% | 0.00% | +50.0% |
Q1 2015 | $15,000 | – | 508 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |